Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice

Luke Esposito, Jacob Raber, Lisa Kekonius, Fengrong Yan, Giu Qiu Yu, Nga Bien-Ly, Jukka Puoliväli, Kimberly Scearce-Levie, Eliezer Masliah, Lennart Mucke

Research output: Contribution to journalArticle

148 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is associated with accumulations of amyloid-β(Aβ) peptides, oxidative damage, mitochondrial dysfunction, neurodegeneration, and dementia. The mitochondrial antioxidant manganese superoxide dismutase-2 (Sod2) might protect against these alterations. To test this hypothesis, we inactivated one Sod2 allele (Sod2+/-) in human amyloid precursor protein (hAPP) transgenic mice, reducing Sod2 activity to ∼50% of that in Sod2 wild-type (Sod2+/+) mice. A reduction in Sod2 activity did not obviously impair mice without hAPP/Aβ expression. In hAPP mice, however, it accelerated the onset of behavioral alterations and of deficits in prepulse inhibition of acoustic startle, a measure of sensorimotor gating. In these mice, it also worsened hAPP/Aβ-dependent depletion of microtubule-associated protein 2, a marker of neuronal dendrites. Sod2 reduction decreased amyloid plaques in the brain parenchyma but promoted the development of cerebrovascular amyloidosis, gliosis, and plaque-independent neuritic dystrophy. Sod2 reduction also increased the DNA binding activity of the transcription factor nuclear factor κB. These results suggest that Sod2 protects the aging brain against hAPP/Aβ-induced impairments. Whereas reductions in Sod2 would be expected to trigger or exacerbate neuronal and vascular pathology in AD, increasing Sod2 activity might be of therapeutic benefit.

Original languageEnglish (US)
Pages (from-to)5167-5179
Number of pages13
JournalJournal of Neuroscience
Volume26
Issue number19
DOIs
StatePublished - 2006

Fingerprint

Amyloid beta-Protein Precursor
Transgenic Mice
Superoxide Dismutase
Alzheimer Disease
Pathology
Serum Amyloid A Protein
Amyloid Plaques
superoxide dismutase 2
Sensory Gating
Gliosis
Microtubule-Associated Proteins
Brain
Amyloidosis
Dendrites
Amyloid
Acoustics
Blood Vessels
Dementia
Transcription Factors
Antioxidants

Keywords

  • Alzheimer's disease
  • Amyloid precursor protein
  • Behavior
  • Mitochondria
  • Superoxide dismutase-2
  • Transgenic mice

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. / Esposito, Luke; Raber, Jacob; Kekonius, Lisa; Yan, Fengrong; Yu, Giu Qiu; Bien-Ly, Nga; Puoliväli, Jukka; Scearce-Levie, Kimberly; Masliah, Eliezer; Mucke, Lennart.

In: Journal of Neuroscience, Vol. 26, No. 19, 2006, p. 5167-5179.

Research output: Contribution to journalArticle

Esposito, Luke ; Raber, Jacob ; Kekonius, Lisa ; Yan, Fengrong ; Yu, Giu Qiu ; Bien-Ly, Nga ; Puoliväli, Jukka ; Scearce-Levie, Kimberly ; Masliah, Eliezer ; Mucke, Lennart. / Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. In: Journal of Neuroscience. 2006 ; Vol. 26, No. 19. pp. 5167-5179.
@article{b8ce8bac7e6047249146ff8983173d59,
title = "Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice",
abstract = "Alzheimer's disease (AD) is associated with accumulations of amyloid-β(Aβ) peptides, oxidative damage, mitochondrial dysfunction, neurodegeneration, and dementia. The mitochondrial antioxidant manganese superoxide dismutase-2 (Sod2) might protect against these alterations. To test this hypothesis, we inactivated one Sod2 allele (Sod2+/-) in human amyloid precursor protein (hAPP) transgenic mice, reducing Sod2 activity to ∼50{\%} of that in Sod2 wild-type (Sod2+/+) mice. A reduction in Sod2 activity did not obviously impair mice without hAPP/Aβ expression. In hAPP mice, however, it accelerated the onset of behavioral alterations and of deficits in prepulse inhibition of acoustic startle, a measure of sensorimotor gating. In these mice, it also worsened hAPP/Aβ-dependent depletion of microtubule-associated protein 2, a marker of neuronal dendrites. Sod2 reduction decreased amyloid plaques in the brain parenchyma but promoted the development of cerebrovascular amyloidosis, gliosis, and plaque-independent neuritic dystrophy. Sod2 reduction also increased the DNA binding activity of the transcription factor nuclear factor κB. These results suggest that Sod2 protects the aging brain against hAPP/Aβ-induced impairments. Whereas reductions in Sod2 would be expected to trigger or exacerbate neuronal and vascular pathology in AD, increasing Sod2 activity might be of therapeutic benefit.",
keywords = "Alzheimer's disease, Amyloid precursor protein, Behavior, Mitochondria, Superoxide dismutase-2, Transgenic mice",
author = "Luke Esposito and Jacob Raber and Lisa Kekonius and Fengrong Yan and Yu, {Giu Qiu} and Nga Bien-Ly and Jukka Puoliv{\"a}li and Kimberly Scearce-Levie and Eliezer Masliah and Lennart Mucke",
year = "2006",
doi = "10.1523/JNEUROSCI.0482-06.2006",
language = "English (US)",
volume = "26",
pages = "5167--5179",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "19",

}

TY - JOUR

T1 - Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice

AU - Esposito, Luke

AU - Raber, Jacob

AU - Kekonius, Lisa

AU - Yan, Fengrong

AU - Yu, Giu Qiu

AU - Bien-Ly, Nga

AU - Puoliväli, Jukka

AU - Scearce-Levie, Kimberly

AU - Masliah, Eliezer

AU - Mucke, Lennart

PY - 2006

Y1 - 2006

N2 - Alzheimer's disease (AD) is associated with accumulations of amyloid-β(Aβ) peptides, oxidative damage, mitochondrial dysfunction, neurodegeneration, and dementia. The mitochondrial antioxidant manganese superoxide dismutase-2 (Sod2) might protect against these alterations. To test this hypothesis, we inactivated one Sod2 allele (Sod2+/-) in human amyloid precursor protein (hAPP) transgenic mice, reducing Sod2 activity to ∼50% of that in Sod2 wild-type (Sod2+/+) mice. A reduction in Sod2 activity did not obviously impair mice without hAPP/Aβ expression. In hAPP mice, however, it accelerated the onset of behavioral alterations and of deficits in prepulse inhibition of acoustic startle, a measure of sensorimotor gating. In these mice, it also worsened hAPP/Aβ-dependent depletion of microtubule-associated protein 2, a marker of neuronal dendrites. Sod2 reduction decreased amyloid plaques in the brain parenchyma but promoted the development of cerebrovascular amyloidosis, gliosis, and plaque-independent neuritic dystrophy. Sod2 reduction also increased the DNA binding activity of the transcription factor nuclear factor κB. These results suggest that Sod2 protects the aging brain against hAPP/Aβ-induced impairments. Whereas reductions in Sod2 would be expected to trigger or exacerbate neuronal and vascular pathology in AD, increasing Sod2 activity might be of therapeutic benefit.

AB - Alzheimer's disease (AD) is associated with accumulations of amyloid-β(Aβ) peptides, oxidative damage, mitochondrial dysfunction, neurodegeneration, and dementia. The mitochondrial antioxidant manganese superoxide dismutase-2 (Sod2) might protect against these alterations. To test this hypothesis, we inactivated one Sod2 allele (Sod2+/-) in human amyloid precursor protein (hAPP) transgenic mice, reducing Sod2 activity to ∼50% of that in Sod2 wild-type (Sod2+/+) mice. A reduction in Sod2 activity did not obviously impair mice without hAPP/Aβ expression. In hAPP mice, however, it accelerated the onset of behavioral alterations and of deficits in prepulse inhibition of acoustic startle, a measure of sensorimotor gating. In these mice, it also worsened hAPP/Aβ-dependent depletion of microtubule-associated protein 2, a marker of neuronal dendrites. Sod2 reduction decreased amyloid plaques in the brain parenchyma but promoted the development of cerebrovascular amyloidosis, gliosis, and plaque-independent neuritic dystrophy. Sod2 reduction also increased the DNA binding activity of the transcription factor nuclear factor κB. These results suggest that Sod2 protects the aging brain against hAPP/Aβ-induced impairments. Whereas reductions in Sod2 would be expected to trigger or exacerbate neuronal and vascular pathology in AD, increasing Sod2 activity might be of therapeutic benefit.

KW - Alzheimer's disease

KW - Amyloid precursor protein

KW - Behavior

KW - Mitochondria

KW - Superoxide dismutase-2

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=33646922865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646922865&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.0482-06.2006

DO - 10.1523/JNEUROSCI.0482-06.2006

M3 - Article

C2 - 16687508

AN - SCOPUS:33646922865

VL - 26

SP - 5167

EP - 5179

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 19

ER -